These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Brimonidine tartrate poisoning in children: frequency, trends, and use of naloxone as an antidote. Lai Becker M; Huntington N; Woolf AD Pediatrics; 2009 Feb; 123(2):e305-11. PubMed ID: 19124581 [TBL] [Abstract][Full Text] [Related]
4. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers. Mungan NK; Wilson TW; Nischal KK; Koren G; Levin AV J AAPOS; 2003 Feb; 7(1):69-70. PubMed ID: 12690374 [TBL] [Abstract][Full Text] [Related]
5. Clinical effects of brimonidine ophthalmic drops ingestion in 52 dogs. Welch SL; Richardson JA Vet Hum Toxicol; 2002 Feb; 44(1):34-5. PubMed ID: 11824775 [TBL] [Abstract][Full Text] [Related]
9. Severe Central Nervous System and Respiratory Depression in a Neonate Following Accidental Oral Ingestion of Brimonidine Tartrate. Gul F; Shah M; Waqar M; Bassi R; Shah S; Sethi N Cureus; 2024 Jun; 16(6):e63124. PubMed ID: 39055420 [TBL] [Abstract][Full Text] [Related]
10. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients. Toris CB; Camras CB; Yablonski ME Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088 [TBL] [Abstract][Full Text] [Related]
11. [Depression of respiration via toxic effects on the central nervous system following use of topical brimonidine in an infant with congenital glaucoma]. Heimann K; Peschgens T; Merz U; Hoernchen H; Wenzl T Ophthalmologe; 2007 Jun; 104(6):505-7. PubMed ID: 17334744 [TBL] [Abstract][Full Text] [Related]
12. Is brimonidine ophthalmic a safe therapy for infants? Daubert GP J Clin Pharm Ther; 2006 Jun; 31(3):289-92. PubMed ID: 16789995 [TBL] [Abstract][Full Text] [Related]
13. Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone. Tobarran N; Kershner E; Chambers A; Cumpston KL; Wills BK Am J Emerg Med; 2022 Sep; 59():218.e5-218.e6. PubMed ID: 35835657 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents. Maus TL; Nau C; Brubaker RF Arch Ophthalmol; 1999 May; 117(5):586-91. PubMed ID: 10326954 [TBL] [Abstract][Full Text] [Related]
15. Ophthalmic drops causing coma in an infant. Berlin RJ; Lee UT; Samples JR; Rich LF; Tang-Liu DD; Sing KA; Steiner RD J Pediatr; 2001 Mar; 138(3):441-3. PubMed ID: 11241061 [TBL] [Abstract][Full Text] [Related]
16. Apparent central nervous system depression in infants after the use of topical brimonidine. Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196 [TBL] [Abstract][Full Text] [Related]
17. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. Schuman JS Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839 [TBL] [Abstract][Full Text] [Related]
18. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment. Greenfield DS; Liebmann JM; Ritch R J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305 [TBL] [Abstract][Full Text] [Related]
19. The evolving pharmacotherapeutic profile of brimonidine, an alpha 2-adrenergic agonist, after four years of continuous use. Cantor LB Expert Opin Pharmacother; 2000 May; 1(4):815-34. PubMed ID: 11249518 [TBL] [Abstract][Full Text] [Related]
20. The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension. Carlsson AM; Chauhan BC; Lee AA; LeBlanc RP Am J Ophthalmol; 2000 Mar; 129(3):297-301. PubMed ID: 10704543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]